Showing 1 - 3 results of 3 for search 'Hiroaki Masubuchi' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • Hiroaki Masubuchi
Showing 1 - 3 results of 3 for search 'Hiroaki Masubuchi', query time: 0.77s Refine Results
  1. 1
    Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity
    Reduced transient receptor potential vanilloid 2 expression in alveolar macrophages causes COPD in mice through impaired phagocytic activity
    by Hiroaki Masubuchi, Manabu Ueno, Toshitaka Maeno, Koichi Yamaguchi, Kenichiro Hara, Hiroaki Sunaga, Hiroki Matsui, Masahiro Nagasawa, Itaru Kojima, Yuko Iwata, Shigeo Wakabayashi, Masahiko Kurabayashi
    Published 2019-03-01
    Get full text
    Article
  2. 2
    A case of Trousseau syndrome caused by pulmonary adenocarcinoma that was controlled for one year and 10 months with thrombosis treatment using an EGFR tyrosine kinase inhibitor and chemotherapy
    A case of Trousseau syndrome caused by pulmonary adenocarcinoma that was controlled for one year and 10 months with thrombosis treatment using an EGFR tyrosine kinase inhibitor and...
    by Hiroaki Masubuchi, Toshitaka Maeno, Megumi Uchida, Shunichi Kono, Masafumi Suzuki, Masao Takemura, Aya Yamaguchi, Koichi Yamaguchi, Masahiko Kanbe, Shinsuke Kitahara, Kenichiro Hara, Shiro Hara, Nozomi Aoki, Tatsuo Suga, Masahiko Kurabayashi
    Published 2015-01-01
    Get full text
    Article
  3. 3
    Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus
    Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus
    by Masao Takemura, Mitsuru Motegi, Yuya Kuroiwa, Miki Itai, Kohei Taguchi, Kazue Umetsu, Megumi Uchida, Shunichi Kouno, Mari Sato, Hiroaki Masubuchi, Aya Yamaguchi, Koichi Yamaguchi, Kana Ikeda, Junichi Nakagawa, Toshitaka Maeno
    Published 2021-01-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...